We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

From Genome Engineering to COVID-19 Diagnostic Testing at IGI
Industry Insight

The Innovative Genomics Institute (IGI) has launched an impressive COVID-19 diagnostic testing laboratory at UC Berkeley. Technology Networks spoke with Professor Jennifer Doudna, Executive Director at IGI and Professor of Molecular and Cell Biology and Chemistry at the University of California, Berkeley, to learn exactly how this ambitious effort has been achieved.

Read More

Asset Monitoring in the Life Sciences: Do Labs Need To Keep a Closer Eye on Their Instruments?
Industry Insight

In the day-to-day of research science, the acquisition of a new piece of equipment is a momentous occasion, but one that could see costs and inefficiencies spiral unless labs keep a close eye on their new kit. Asset monitoring software could lend a hand. We spoke to Agilent's Marc Boreham to find out more.

Read More

13 COVID-19 Vaccines Are in Human Clinical Trials – What Are They?
Industry Insight

The World Health Organization recognizes that, as of June 22, there are over 140 vaccines against COVID-19 in various stages of development. 13 of those candidates are now in human clinical trials. In this insights piece, we explore what those candidates are, and who is developing them.

Read More

Moving Ions Around Corners To Revolutionize Disease Detection and Biotherapeutic Development
Industry Insight

The study of proteins, lipids, metabolites and other related molecules are invaluable in early disease detection and biotherapeutic development. An innovative separation technology borne out of a US Federal Laboratory, known as structures for lossless ion manipulation, is helping scientists to achieving this.

Read More

Metagenomics As a Tool To Diagnose and Understand COVID-19
Industry Insight

To learn how clinical metagenomics can be used as a tool to diagnose and understand pathogens such as SARS-CoV-2, Technology Networks recently spoke with Robert Schlaberg, co-founder and CMO of IDbyDNA.

Read More

Pathology Post COVID-19
Industry Insight

To learn more about the impact the COVID-19 pandemic is having on pathology, what the future of pathology might look like, and how digital pathology could help to ease some of the challenges, we spoke to Mark Lloyd, Founder and Executive Vice President of Inspirata.

Read More

Can Teletherapy Help People With OCD During the COVID-19 Pandemic?
Industry Insight

Whilst the coronavirus pandemic and associated lockdown has taken a toll on everyone’s mental health, the burden has been especially heavy for people living with obsessive compulsive disorder (OCD). We spoke to NOCD’s founder Stephen Smith, who has experienced the crippling impact of OCD in his own life, on how his remote counselling service could help people with OCD during the pandemic.

Read More

Exploring the Therapeutic Potential of ST266 Against Numerous Diseases Including COVID-19
Industry Insight

Technology Networks recently spoke with William J. Golden, Noveome Biotherapeutics’ Founder, Chairman and CEO, who explains the underlying basis for investigating ST266’s potential against COVID-19. Golden also elaborates on many of the other indications for which ST266 is being developed to treat.

Read More

Taking a Closer Look at Trends in Microscopy
Industry Insight

With advances in cellular and tissue-based imaging, researchers are able to peel back the layers on new challenges and test hypotheses to solve more problems. We heard about some of the advancements being made in the field of confocal microscopy.

Read More

Telehealth’s Time Is Now. Can It Take a Leading Role?
Industry Insight

Telehealth is booming. An industry which has long shown its value in long-distance and rural healthcare settings has been moved center stage by the COVID-19 pandemic. We spoke to Daniel Carlin, CEO of provider WorldClinic to discuss the need for care consistency in telehealth, the impact of COVID-19 and whether bespoke telehealth services can become truly mainstream.

Read More

 
Advertisement